Skip to main content
Equibles

BARCLAYS PLC

Position in FENC — Fennec Pharmaceuticals Inc.

CIK 312069 LONDON, X0
Back to FENC Full portfolio

Position in FENC

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$46,804
+$8,226 QoQ
Shares Held
4,354
-30.6% QoQ
Ownership
0.012%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
21 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in FENC Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

BARCLAYS PLC holds $1,710,275,160 across 455 Biotechnology names. FENC ranks #280 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 733,274 $364,239,192
2 REGN
Regeneron Pharmaceuticals, Inc.
 256,192 $159,745,957
3 IONS
Ionis Pharmaceuticals Inc
 1,603,136 $127,112,653
4 ARGX
Argenx SE
 134,427 $124,717,337
5 MRNA
Moderna, Inc.
 1,035,126 $72,489,872
6 BBIO
BridgeBio Pharma, Inc.
 714,423 $53,210,224
7 TGTX
Tg Therapeutics, Inc.
 957,848 $52,624,168
8 DNTH
Dianthus Therapeutics, Inc. /DE/
 431,753 $42,087,281

All Filings in FENC

Export CSV
21 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $46,804 4,354
2026-03-31 $38,578 6,273
2025-12-31 $281,796 36,597
2025-09-30 $309,234 33,038
2025-06-30 $332,040 40,005
2025-03-31 $147,993 24,301
2024-12-31 $225,447 35,672
2024-09-30 $156,595 31,319
2024-06-30 $51,128 8,368
2024-03-31 $143,181 12,876
2023-12-31 $281,341 25,075
2023-09-30 $25,984 3,460
2023-06-30 $32,097 3,635
2023-03-31 $80,678 9,697
2022-12-31 $88,896 9,260
2021-09-30 $24,944 2,648
2021-06-30 $21,826 2,994
2021-03-31 $112,984 18,194
2020-12-31 $52,328 7,024
2020-09-30 $59,406 9,803
2020-06-30 $99,907 11,965